These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28288662)

  • 1. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
    Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D
    Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong
    Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.
    Rustanti L; Jin H; Li D; Lor M; Sivakumaran H; Harrich D
    Virol Sin; 2018 Apr; 33(2):142-152. PubMed ID: 29541943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.
    Apolloni A; Lin MH; Sivakumaran H; Li D; Kershaw MH; Harrich D
    Hum Gene Ther; 2013 Mar; 24(3):270-82. PubMed ID: 23298160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.
    Lin MH; Apolloni A; Cutillas V; Sivakumaran H; Martin S; Li D; Wei T; Wang R; Jin H; Spann K; Harrich D
    J Virol; 2015 May; 89(9):4827-36. PubMed ID: 25673710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.
    Lin MH; Sivakumaran H; Apolloni A; Wei T; Jans DA; Harrich D
    PLoS One; 2012; 7(12):e51466. PubMed ID: 23251541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.
    Okamoto M; Chono H; Kawano Y; Saito N; Tsuda H; Inoue K; Kato I; Mineno J; Baba M
    Hum Gene Ther Methods; 2013 Apr; 24(2):94-103. PubMed ID: 23442049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of HIV-1 replication by a Tat mutant.
    Meredith LW; Sivakumaran H; Major L; Suhrbier A; Harrich D
    PLoS One; 2009 Nov; 4(11):e7769. PubMed ID: 19901984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
    Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
    Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
    Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
    AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
    Jin H; Li D; Lin MH; Li L; Harrich D
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells and monocytes derived from CD34+ cells transduced with an intracellular antibody directed against human immunodeficiency virus type 1 Tat.
    Poznansky MC; La Vecchio J; Silva-Arietta S; Porter-Brooks J; Brody K; Olszak IT; Adams GB; Ramstedt U; Marasco WA; Scadden DT
    Hum Gene Ther; 1999 Oct; 10(15):2505-14. PubMed ID: 10543615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.
    Chono H; Matsumoto K; Tsuda H; Saito N; Lee K; Kim S; Shibata H; Ageyama N; Terao K; Yasutomi Y; Mineno J; Kim S; Inouye M; Kato I
    Hum Gene Ther; 2011 Jan; 22(1):35-43. PubMed ID: 20649483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.